77281-03-9

Basic information

• Product Name: SodiuM 2-Methoxyethanesulfonate
• Synonyms: SodiuM 2-Methoxyethanesulfonate
• CAS NO: 77281-03-9
• Molecular Formula: C3H7NaO4S
• Molecular Weight: 162
• Mol File: 77281-03-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: SodiuM 2-Methoxyethanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: SodiuM 2-Methoxyethanesulfonate(77281-03-9)
• EPA Substance Registry System: SodiuM 2-Methoxyethanesulfonate(77281-03-9)

Safety Data

• Hazardous Substances Data: 77281-03-9(Hazardous Substances Data)

Usage

General Description

Sodium 2-Methoxyethanesulfonate is a chemical compound that is used as a solvent and electrolyte in various processes such as electrochemistry, polymerization, and as a reagent in organic synthesis. It is water-soluble and has low toxicity, making it suitable for use in a wide range of applications. The compound is known for its ability to stabilize reactive species and intermediates in chemical reactions, as well as for its high thermal stability and low vapor pressure. Overall, Sodium 2-Methoxyethanesulfonate is a versatile and useful chemical that plays a significant role in various industrial and research-related processes.

Upstream product

• 6482-24-2 2-Bromoethyl methyl ether 
• 627-42-9 2-chloroethyl methyl ether 

Downstream Products

• 51517-01-2 2-methoxyethane-1-sulfonyl chloride 

Relevant articles and documents

THIAZOLIDINONE COMPOUNDS AND USE THEREOF

A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

NITROGENATED HETEROCYCLIC COMPOUND

A nitrogen-containing heterocyclic compound represented by formula (I-A): (wherein R1A represents lower alkyl which may be substituted with lower alkoxy, R3A represents lower alkyl substituted with fluorine atom(s), and RqA represents an optionally substituted aromatic heterocyclic group) or the like, or a pharmaceutically acceptable salt thereof; and the like, are provided.

Pyrrolopyrazinyl Urea Kinase Inhibitors

The present invention relates to the use of novel pyrrolopyrazinyl urea derivatives of Formula I, wherein the variables R1, R2, R3, R4, and R5 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.